Logo image of ALVIV.PA

VISIATIV SA (ALVIV.PA) Stock Fundamental Analysis

EPA:ALVIV - Euronext Paris - Matif - FR0004029478 - Common Stock - Currency: EUR

37  +0.1 (+0.27%)

Fundamental Rating

4

ALVIV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 74 industry peers in the IT Services industry. There are concerns on the financial health of ALVIV while its profitability can be described as average. While showing a medium growth rate, ALVIV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALVIV had positive earnings in the past year.
In the past year ALVIV had a positive cash flow from operations.
In the past 5 years ALVIV has always been profitable.
In the past 5 years ALVIV always reported a positive cash flow from operatings.
ALVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFALVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M 25M

1.2 Ratios

With a Return On Assets value of 2.85%, ALVIV perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
With a decent Return On Equity value of 13.14%, ALVIV is doing good in the industry, outperforming 60.32% of the companies in the same industry.
The Return On Invested Capital of ALVIV (6.92%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALVIV is below the industry average of 10.94%.
Industry RankSector Rank
ROA 2.85%
ROE 13.14%
ROIC 6.92%
ROA(3y)3.27%
ROA(5y)2.33%
ROE(3y)15.28%
ROE(5y)11.1%
ROIC(3y)7.35%
ROIC(5y)6.7%
ALVIV.PA Yearly ROA, ROE, ROICALVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

ALVIV has a Profit Margin (3.60%) which is in line with its industry peers.
ALVIV's Profit Margin has improved in the last couple of years.
ALVIV has a Operating Margin (6.23%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALVIV has grown nicely.
ALVIV has a Gross Margin (70.23%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALVIV has grown nicely.
Industry RankSector Rank
OM 6.23%
PM (TTM) 3.6%
GM 70.23%
OM growth 3Y17.05%
OM growth 5Y2.75%
PM growth 3Y67.21%
PM growth 5Y12.34%
GM growth 3Y1.22%
GM growth 5Y1.82%
ALVIV.PA Yearly Profit, Operating, Gross MarginsALVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALVIV is creating some value.
The number of shares outstanding for ALVIV has been increased compared to 1 year ago.
ALVIV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALVIV has been reduced compared to a year ago.
ALVIV.PA Yearly Shares OutstandingALVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALVIV.PA Yearly Total Debt VS Total AssetsALVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

ALVIV has an Altman-Z score of 1.52. This is a bad value and indicates that ALVIV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALVIV (1.52) is worse than 69.84% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that ALVIV has dependencies on debt financing.
ALVIV has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: ALVIV underperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC1.1
WACC6.31%
ALVIV.PA Yearly LT Debt VS Equity VS FCFALVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

ALVIV has a Current Ratio of 1.13. This is a normal value and indicates that ALVIV is financially healthy and should not expect problems in meeting its short term obligations.
ALVIV has a Current ratio (1.13) which is comparable to the rest of the industry.
A Quick Ratio of 1.13 indicates that ALVIV should not have too much problems paying its short term obligations.
ALVIV's Quick ratio of 1.13 is in line compared to the rest of the industry. ALVIV outperforms 46.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
ALVIV.PA Yearly Current Assets VS Current LiabilitesALVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ALVIV have decreased strongly by -12.29% in the last year.
The Earnings Per Share has been growing by 21.66% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 7.23% in the past year.
ALVIV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.20% yearly.
EPS 1Y (TTM)-12.29%
EPS 3Y79.02%
EPS 5Y21.66%
EPS Q2Q%-35.61%
Revenue 1Y (TTM)7.23%
Revenue growth 3Y13.47%
Revenue growth 5Y11.2%
Sales Q2Q%4.38%

3.2 Future

Based on estimates for the next years, ALVIV will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.46% on average per year.
ALVIV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.74% yearly.
EPS Next Y-12.18%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
EPS Next 5YN/A
Revenue Next Year6.94%
Revenue Next 2Y7.05%
Revenue Next 3Y6.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVIV.PA Yearly Revenue VS EstimatesALVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALVIV.PA Yearly EPS VS EstimatesALVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALVIV is valuated rather expensively with a Price/Earnings ratio of 17.05.
68.25% of the companies in the same industry are more expensive than ALVIV, based on the Price/Earnings ratio.
ALVIV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.04.
The Price/Forward Earnings ratio is 17.63, which indicates a rather expensive current valuation of ALVIV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVIV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.64, ALVIV is valued rather cheaply.
Industry RankSector Rank
PE 17.05
Fwd PE 17.63
ALVIV.PA Price Earnings VS Forward Price EarningsALVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ALVIV's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.52
ALVIV.PA Per share dataALVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ALVIV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.79
EPS Next 2Y4.17%
EPS Next 3Y9.46%

More info and screens

6

5. Dividend

5.1 Amount

ALVIV has a Yearly Dividend Yield of 5.02%, which is a nice return.
Compared to an average industry Dividend Yield of 6.95, ALVIV pays a better dividend. On top of this ALVIV pays more dividend than 87.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, ALVIV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALVIV.PA Yearly Dividends per shareALVIV.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

ALVIV pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
ALVIV.PA Yearly Income VS Free CF VS DividendALVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M
ALVIV.PA Dividend Payout.ALVIV.PA Dividend Payout, showing the Payout Ratio.ALVIV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

VISIATIV SA

EPA:ALVIV (8/14/2024, 7:00:00 PM)

37

+0.1 (+0.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-24 2024-07-24
Earnings (Next)10-22 2024-10-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap169.90M
Analysts44.44
Price Target37.4 (1.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.02%
Yearly Dividend1.11
Dividend Growth(5Y)N/A
DP50%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.49%
EPS NY rev (3m)-6.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.08%
Valuation
Industry RankSector Rank
PE 17.05
Fwd PE 17.63
P/S 0.61
P/FCF N/A
P/OCF 12.87
P/B 2.23
P/tB N/A
EV/EBITDA 8.52
EPS(TTM)2.17
EY5.86%
EPS(NY)2.1
Fwd EY5.67%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)2.87
OCFY7.77%
SpS60.43
BVpS16.57
TBVpS-17.73
PEG (NY)N/A
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 13.14%
ROCE 9.14%
ROIC 6.92%
ROICexc 9.72%
ROICexgc N/A
OM 6.23%
PM (TTM) 3.6%
GM 70.23%
FCFM N/A
ROA(3y)3.27%
ROA(5y)2.33%
ROE(3y)15.28%
ROE(5y)11.1%
ROIC(3y)7.35%
ROIC(5y)6.7%
ROICexc(3y)11.38%
ROICexc(5y)10.34%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.71%
ROCE(5y)8.86%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y11.15%
ROICexc growth 5Y-0.43%
OM growth 3Y17.05%
OM growth 5Y2.75%
PM growth 3Y67.21%
PM growth 5Y12.34%
GM growth 3Y1.22%
GM growth 5Y1.82%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 3.44
Cap/Depr 140.63%
Cap/Sales 4.86%
Interest Coverage 250
Cash Conversion 49.07%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 1.52
F-Score5
WACC6.31%
ROIC/WACC1.1
Cap/Depr(3y)146%
Cap/Depr(5y)132.7%
Cap/Sales(3y)4.96%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.29%
EPS 3Y79.02%
EPS 5Y21.66%
EPS Q2Q%-35.61%
EPS Next Y-12.18%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
EPS Next 5YN/A
Revenue 1Y (TTM)7.23%
Revenue growth 3Y13.47%
Revenue growth 5Y11.2%
Sales Q2Q%4.38%
Revenue Next Year6.94%
Revenue Next 2Y7.05%
Revenue Next 3Y6.74%
Revenue Next 5YN/A
EBIT growth 1Y-8.95%
EBIT growth 3Y32.82%
EBIT growth 5Y14.26%
EBIT Next Year64.27%
EBIT Next 3Y21.88%
EBIT Next 5YN/A
FCF growth 1Y-104.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.87%
OCF growth 3Y-2.92%
OCF growth 5Y11.59%